neostigmine

Generic: neostigmine

Labeler: dr.reddy's laboratories inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name neostigmine
Generic Name neostigmine
Labeler dr.reddy's laboratories inc
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

neostigmine methylsulfate .5 mg/mL

Manufacturer
Dr.Reddy's Laboratories Inc

Identifiers & Regulatory

Product NDC 43598-528
Product ID 43598-528_649d8760-81df-13da-6556-14a0fdbc8b02
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209135
Listing Expiration 2026-12-31
Marketing Start 2018-09-04

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43598528
Hyphenated Format 43598-528

Supplemental Identifiers

RxCUI
311935 311936
UPC
0343598528113 0343598529110
UNII
98IMH7M386

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name neostigmine (source: ndc)
Generic Name neostigmine (source: ndc)
Application Number ANDA209135 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • .5 mg/mL
source: ndc
Packaging
  • 1 VIAL, MULTI-DOSE in 1 CARTON (43598-528-11) / 10 mL in 1 VIAL, MULTI-DOSE
  • 10 VIAL, MULTI-DOSE in 1 CARTON (43598-528-36) / 10 mL in 1 VIAL, MULTI-DOSE
source: ndc

Packages (2)

Ingredients (1)

neostigmine methylsulfate (.5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "649d8760-81df-13da-6556-14a0fdbc8b02", "openfda": {"upc": ["0343598528113", "0343598529110"], "unii": ["98IMH7M386"], "rxcui": ["311935", "311936"], "spl_set_id": ["81243f47-bd25-bd02-518a-087badcca755"], "manufacturer_name": ["Dr.Reddy's Laboratories Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (43598-528-11)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "43598-528-11", "marketing_start_date": "20180904"}, {"sample": false, "description": "10 VIAL, MULTI-DOSE in 1 CARTON (43598-528-36)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "43598-528-36", "marketing_start_date": "20180904"}], "brand_name": "Neostigmine", "product_id": "43598-528_649d8760-81df-13da-6556-14a0fdbc8b02", "dosage_form": "INJECTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "43598-528", "generic_name": "Neostigmine", "labeler_name": "Dr.Reddy's Laboratories Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Neostigmine", "active_ingredients": [{"name": "NEOSTIGMINE METHYLSULFATE", "strength": ".5 mg/mL"}], "application_number": "ANDA209135", "marketing_category": "ANDA", "marketing_start_date": "20180904", "listing_expiration_date": "20261231"}